SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001683168-17-002609
Filing Date
2017-10-10
Accepted
2017-10-10 08:23:56
Documents
1
Group Members
BRISTOL CAPITAL, LLCBRISTOL INVESTMENT FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 bristol_gt-sc13ga9.htm SC 13G/A 64642
  Complete submission text file 0001683168-17-002609.txt   66626
Mailing Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602
Business Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 171128738
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205
Business Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205 (310) 331-8485
BRISTOL INVESTMENT FUND LTD (Filed by) CIK: 0001174866 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A